Department of Community Health Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA.
UNC Lineberger Comprehensive Cancer Center, School of Medicine, UNC Chapel Hill, Chapel Hill, NC 27514, USA.
Int J Environ Res Public Health. 2021 Feb 24;18(5):2231. doi: 10.3390/ijerph18052231.
This study sought to evaluate COVID-19 associated physical and mental health symptoms among adults with allergies compared to the general U.S. adult population.
Data for these analyses were obtained from the publicly available COVID-19 Household Impact Survey, which provides national and regional statistics about physical health, mental health, economic security, and social dynamics among U.S. adults (ages 18 and older). Data from 20-26 April 2020; 4-10 May 2020; and 30 May-8 June 2020 were included. Our primary outcomes for this analysis were physical and mental health symptoms experienced in the last seven days. The primary predictor was participants' self-report of a physician diagnosis of an allergy.
RESULTS/DISCUSSION: This study included 10,760 participants, of whom 44% self-reported having allergies. Adults with allergies were more likely to report physical symptoms compared to adults without allergies including fever (aOR 1.7, 95% CI 1.44-1.99), cough (aOR 1.9, 95% CI 1.60-2.26), shortness of breath (aOR 2.04, 95% CI 1.71-2.43), and loss of taste or sense of smell (aOR 1.9, 95% CI 1.58-2.28). Adults with allergies were more likely to report feeling nervous (cOR 1.34, 95% CI 1.13, 1.60), depressed (cOR 1.32, 95% CI 1.11-1.57), lonely (cOR 1.23, 95% CI 1.04-1.47), hopeless (cOR 1.44, 95% CI 1.21-1.72), or having physical reactions when thinking about COVID-19 pandemic (cOR 2.01, 95% CI 1.44-2.82), compared to those without allergies. During the COVID-19 pandemic, adults with allergies are more likely to report physical and mental health symptoms compared to individuals without allergies. These findings have important implications for diagnostic and treatment challenges for allergy physicians.
本研究旨在评估与过敏相关的成年人 COVID-19 相关的身体和心理健康症状与美国一般成年人相比。
这些分析的数据来自公开的 COVID-19 家庭影响调查，该调查提供了美国成年人（18 岁及以上）的身体健康、心理健康、经济安全和社会动态的国家和地区统计数据。纳入了 2020 年 4 月 20-26 日；5 月 4-10 日；5 月 30 日-6 月 8 日的数据。我们的主要结局指标为过去 7 天内出现的身体和心理健康症状。主要预测指标为参与者自我报告的医生诊断的过敏。
结果/讨论：本研究纳入了 10760 名参与者，其中 44%自我报告有过敏。与没有过敏的成年人相比，过敏成年人更有可能报告身体症状，包括发烧（aOR 1.7，95%CI 1.44-1.99）、咳嗽（aOR 1.9，95%CI 1.60-2.26）、呼吸急促（aOR 2.04，95%CI 1.71-2.43）和味觉或嗅觉丧失（aOR 1.9，95%CI 1.58-2.28）。过敏的成年人更有可能感到紧张（cOR 1.34，95%CI 1.13-1.60）、抑郁（cOR 1.32，95%CI 1.11-1.57）、孤独（cOR 1.23，95%CI 1.04-1.47）、绝望（cOR 1.44，95%CI 1.21-1.72），或一想到 COVID-19 大流行就有身体反应（cOR 2.01，95%CI 1.44-2.82），与没有过敏的成年人相比。在 COVID-19 大流行期间，与没有过敏的个体相比，过敏的成年人更有可能报告身体和心理健康症状。这些发现对过敏医生的诊断和治疗挑战具有重要意义。
